Tolero Pharmaceuticals Joins The Leukemia & Lymphoma Society\’s Groundbreaking Beat AML Master Clinical Trial for Patients with Acute Myeloid Leukemia
Tolero Pharmaceuticals, Inc., a clinical-stage company focused on developing novel therapeutics for hematological and oncological diseases, today announced that it has joined The Leukemia & Lymphoma Society (LLS) in the groundbreaking, collaborative Beat AML Master Clinical Trial for newly diagnosed patients 60 years of age or older with acute myeloid leukemia (AML). Tolero\’s investigational agent, […]